Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Embryonic stem cells: meeting the needs for cell therapy.

Maria Teresa Mitjavila-Garcia1, Clémence Simonin, Marc Peschanski

  • 1INSERM U 421, I-STEM, Faculté dc Médecine, 94010 Créteil Cedex, France.

Advanced Drug Delivery Reviews
|November 1, 2005
PubMed
Summary

Human embryonic stem (ES) cells offer a promising solution for cell banking challenges in regenerative medicine. These cells could meet the needs for large-scale therapeutic cell production for various degenerative diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative analysis of drug-gene signatures in human pluripotent stem cells reveals prazosin as a novel SQSTM1 regulator for ALS therapeutics.

Stem cell reports·2026
Same author

Comparison of tetrabenazine, tiapride and olanzapine in Huntington's disease: a one-year French randomized multicenter study (Neuro-HD).

Parkinsonism & related disorders·2025
Same author

The Use of Image Guided Programming to Improve Deep Brain Stimulation Workflows with Directional Leads in Parkinson's Disease.

Journal of Parkinson's disease·2024
Same author

Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson's disease and pharmacodynamic biomarkers.

NPJ Parkinson's disease·2023
Same author

Crosstalk between the Hippo Pathway and the Wnt Pathway in Huntington's Disease and Other Neurodegenerative Disorders.

Cells·2022
Same author

Clinical Grade Human Pluripotent Stem Cell-Derived Engineered Skin Substitutes Promote Keratinocytes Wound Closure In Vitro.

Cells·2022

Area of Science:

  • Regenerative Medicine
  • Stem Cell Biology
  • Cell Therapy

Background:

  • Cell therapy has advanced for degenerative diseases, but clinical application is limited by the scarcity of specific therapeutic cells (e.g., neurons, beta cells, myoblasts).
  • Current cell therapy successes are hindered by difficulties in obtaining sufficient patient-specific cells for widespread clinical use.
  • The concept of cell banks is crucial for future cell therapy accessibility, but currently limited to hematopoietic stem cells.

Purpose of the Study:

  • To evaluate the potential of human embryonic stem (ES) cells for establishing cell banks.
  • To assess the suitability of human ES cells for substitutive cell therapy applications.
  • To address the limitations in sourcing therapeutic cells for degenerative conditions.

Main Methods:

Related Experiment Videos

  • Review of existing literature on cell therapy, stem cell biology, and cell banking.
  • Analysis of the potential of human ES cells to meet cell banking requirements.
  • Assessment of human ES cells' suitability for therapeutic cell generation.

Main Results:

  • Human ES cells present a viable option for addressing the challenge of therapeutic cell accessibility.
  • ES cells can potentially fulfill the requirements for large-scale cell banking.
  • This approach could enable the development of cell banks for diverse therapeutic needs.

Conclusions:

  • Human ES cells hold significant promise for the future of cell banking in regenerative medicine.
  • Their use could overcome current limitations in providing sufficient cells for treating degenerative diseases.
  • ES cell-based banking is a key step towards realizing widespread clinical cell therapy.